RxDoctor Payments Data

Verdon Parham, MD

Family Medicine · Chanute, KSNPI 1437251964

Payments from drug & device makers

$333in general payments, 2019–2025

Across 18 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$113
  • Mylan Specialty L.p.$56
  • Biohaven Pharmaceutical Holding Company Ltd.$37
  • Pfizer$31
  • Johnson & Johnson$26
  • Eisai Inc.$20
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$333100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$333 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$1,698
Medicare patients
26
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$41,257
EliquisApixaban38$27,621
LinzessLinaclotide42$22,805
JanuviaSitagliptin Phosphate31$19,964
JardianceEmpagliflozin17$17,325
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,522
UbrelvyUbrogepant13$13,508
XareltoRivaroxaban19$13,343
FarxigaDapagliflozin Propanediol19$12,450
OxycontinOxycodone Hcl12$8,154
CreonLipase/Protease/Amylase13$7,817
Breo ElliptaFluticasone/Vilanterol19$7,423
Fentanyl51$6,000
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen136$5,857
Oxycodone Hcl193$5,606

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$31$27,62138 claims
Johnson & JohnsonXarelto$26$13,34319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Chanute

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →